Q Holdings, Inc., dba Q Therapeutics, Inc., an emerging biotechnology company utilizing its proprietary innovative technology to develop breakthrough cell therapy products for the treatment of debilitating diseases of the central nervous system, today announced the issuance of United States Patent No.
http://www.biospace.com/news_story.aspx?StoryID=280782&full=1
http://www.biospace.com/news_story.aspx?StoryID=280782&full=1
No comments:
Post a Comment